pharmaceuticals
pharmaceuticals Articles
Regeneron Pharmaceuticals reported its first-quarter financial results before the markets opened on Tuesday. While the earnings were important, and fairly positive, more investors seemed interested...
Published:
Portola Pharmaceuticals shares more than doubled on Tuesday after the company announced that it would be acquired by Alexion Pharmaceuticals.
Published:
Merck and Pfizer reported their most recent quarterly results before the opening bell Tuesday. Although markets appear to be recovering, investors were not thrilled about this quarter for these two...
Published:
iBio has provided an update on its COVID-19 vaccine manufacturing capacity and said that it has joined the National Institute for Innovation in Manufacturing Biopharmaceuticals.
Published:
Pharmaceutical giants Merck and Pfizer are expected to report their most recent quarterly results before the opening bell Tuesday.
Published:
The April 15 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
BioNTech shares shot up on Wednesday after the company announced, in conjunction with Pfizer, that its COVID-19 vaccine program was approved in Germany.
Published:
Exelixis stock jumped early on Monday after the company, in conjunction with Bristol-Myers Squibb, announced positive late-stage results from its kidney cancer study.
Published:
While the COVID-19 pandemic wrecked the stock market and the economy, the recent rally in the stock market has been at a time when the economic news is only getting worse and as coronavirus news...
Published:
Johnson & Johnson released better than expected quarterly results and hiked its dividend before the markets opened on Tuesday.
Published:
Johnson & Johnson is scheduled to release its fiscal first-quarter financial results before the markets open on Tuesday.
Published:
The March 31 short interest data have been compared with the previous figures, and short interest moves in these selected pharmaceutical stocks were mixed.
Published:
Pfizer and BioNTech each saw gains on Thursday after the companies announced additional details regarding their collaboration in the fight against COVID-19.
Published:
Biotech firm Inovio has begun Phase 1 trials of a new vaccine for COVID-19. The trial is beginning Monday.
Published:
24/7 Wall St. has tracked some health care companies with prospects at crafting a vaccine to deal with this novel coronavirus and where they stand now.
Published: